Appropriateness of empirical therapy in carbapenem-resistant Klebsiella pneumoniae intensive care unit acquired infection: role of surveillance cultures

Infect Dis (Lond). 2016 Aug;48(8):643-5. doi: 10.3109/23744235.2016.1172107. Epub 2016 May 11.

Authors

Francesco Sbrana¹, Paolo Malcarne², Gaia Bernardeschi², Andrea Ripoli¹, Carlo Tascini³

Affiliations

¹ a U.O. Lipoaferesi , Fondazione Toscana Gabriele Monasterio , Via Moruzzi, 1 - Pisa , Italy ;
² b U.O. Anestesia e Rianimazione VI° - Pronto Soccorso , Azienda Ospedaliera Universitaria Pisana , Pisa , Italy ;
³ c U.O. Malattie Infettive , Azienda Ospedaliera Universitaria Pisana , Pisa , Italy.

PMID: 27167235
DOI: 10.3109/23744235.2016.1172107

No abstract available

MeSH terms

Adult
Aged
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use*
Carbapenems / pharmacology*
Cross Infection / drug therapy*
Cross Infection / microbiology
Female
Humans
Inappropriate Prescribing / prevention & control
Klebsiella Infections / drug therapy*
Klebsiella Infections / microbiology
Klebsiella pneumoniae / drug effects*
Male
Middle Aged
Prospective Studies
Public Health Surveillance

Substances

Anti-Bacterial Agents
Carbapenems